These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18508316)

  • 1. Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells.
    Huang S; He X; Ding J; Liang L; Zhao Y; Zhang Z; Yao X; Pan Z; Zhang P; Li J; Wan D; Gu J
    Int J Cancer; 2008 Aug; 123(4):972-8. PubMed ID: 18508316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma.
    Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX
    Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.
    Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H
    Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
    Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy is activated by TGF-beta and potentiates TGF-beta-mediated growth inhibition in human hepatocellular carcinoma cells.
    Kiyono K; Suzuki HI; Matsuyama H; Morishita Y; Komuro A; Kano MR; Sugimoto K; Miyazono K
    Cancer Res; 2009 Dec; 69(23):8844-52. PubMed ID: 19903843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling.
    Hu X; Rui W; Wu C; He S; Jiang J; Zhang X; Yang Y
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1284-91. PubMed ID: 24329763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells.
    Jiang F; Mu J; Wang X; Ye X; Si L; Ning S; Li Z; Li Y
    PLoS One; 2014; 9(5):e96698. PubMed ID: 24806207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
    Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells.
    Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G
    Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
    Mu X; Lin S; Yang J; Chen C; Chen Y; Herzig MC; Washburn K; Halff GA; Walter CA; Sun B; Sun LZ
    PLoS One; 2013; 8(5):e63436. PubMed ID: 23704908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.
    Herzer K; Grosse-Wilde A; Krammer PH; Galle PR; Kanzler S
    Mol Cancer Res; 2008 Jul; 6(7):1169-77. PubMed ID: 18644981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
    Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.
    Yan X; Wu J; Jiang Q; Cheng H; Han JJ; Chen YG
    J Mol Cell Biol; 2018 Feb; 10(1):48-59. PubMed ID: 29036306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
    Zhuo L; Liu J; Wang B; Gao M; Huang A
    Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-based dissection of microRNA-23a ~ 27a ~ 24-2 cluster functionality in hepatocellular carcinoma.
    Cui M; Liu Z; Wang S; Bae S; Guo H; Zhou J; Liu R; Wang L
    Oncogene; 2024 Aug; 43(36):2708-2721. PubMed ID: 39112518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells.
    Cao M; Seike M; Soeno C; Mizutani H; Kitamura K; Minegishi Y; Noro R; Yoshimura A; Cai L; Gemma A
    Int J Oncol; 2012 Sep; 41(3):869-75. PubMed ID: 22752005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells.
    Caja L; Sancho P; Bertran E; Fabregat I
    J Hepatol; 2011 Aug; 55(2):351-8. PubMed ID: 21147185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-181a mediates TGF-β-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer.
    Brockhausen J; Tay SS; Grzelak CA; Bertolino P; Bowen DG; d'Avigdor WM; Teoh N; Pok S; Shackel N; Gamble JR; Vadas M; McCaughan GW
    Liver Int; 2015 Jan; 35(1):240-53. PubMed ID: 24576072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The increase of miR-27a affects the role of cisplatin on proliferation and migration capacities of liver cancer cells.
    Li W; Yu ZX; Ma BF
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5490-5498. PubMed ID: 30229820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.